Psychiatric symptoms related to patients who used medicinal cannabis

Main Article Content

Boonsiri Junsirimongkol
Hathairat Saima-in
Yupha Khongklinsukhon
Chakkraphong Tomood

Abstract

Background and Objective: There is a guideline for caring and report system of medicinal cannabis users in medical cannabis clinic. This research aim to study association between personal data factor, major symptoms for treatment/indications, medicinal cannabis type and occurrence of psychiatric symptoms in patients with medicinal cannabis use.


Method of study: This was a descriptive retrospective study. The secondary data of 6,202 patients receiving medicinal cannabis from the Cannabis Clinic Data Center (C-MOPH) in 2020 was used. Descriptive statistics, multiple logistic regression and chi-square test were applied in analysis of data.


Results: The results found that 96.73% did not find the occurrence of psychiatric symptoms and 3.27% found the occurrence of psychiatric symptoms. Depression was the most found with 2.05%. Only one factor associated with the occurrence of one or more psychiatric symptoms in overall after medicinal cannabis use which was major symptoms for treatment/indications factor. The factor consisted of muscle spasms in patients with multiple sclerosis (MS), Parkinson's disease, other multiple sclerosis, and two or more symptoms (Adj.OR = 3.23, 2.45, 13.57, 2.15 respectively). However, age, sex, major symptoms for treatment/indications and medicinal cannabis type associated with some psychiatric symptoms.


Conclusion: Major symptoms for treatment/indications of medicinal cannabis users associated with the occurrence of psychiatric symptoms.


 

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Junsirimongkol B, Saima-in H, Khongklinsukhon Y, Tomood C. Psychiatric symptoms related to patients who used medicinal cannabis. SRIMEDJ [Internet]. 2022 Feb. 28 [cited 2023 Feb. 7];37(1):82-93. Available from: https://li01.tci-thaijo.org/index.php/SRIMEDJ/article/view/253660
Section
Original Articles

References

Narcotics Control Division Food and Drug Administration. Guideline for patients with cannabis use in Thailand, 2020.

Worawan Thongsuk. Marijuana and agricultural education. Journal of Industrial Education, 2021; 19(1):144-54.

Attasit Srisubat and Somchai Thanasitthichai. Marijuana and conventional medicine. Journal of the Department of Medical Services. 2019; 44(6):5-8.

Bungorn Sripanidkulchai. Medical Uses of Cannabis. Isan Journal of Pharmaceutical Sciences, IJPS. 2019; 15(4): 1-26.

Department of Medical Services, Ministry of Public Health. Advice on the use of medical marijuana 4th revised edition. Nonthaburi; 2021.

Rasmon Kalayasiri and Sakol Srisuklorm. Cannabis and psychiatric disorders: risk factors and medical use. Journal of Mental Health of Thailand 2020;28(4):360-74.

Neuroscience Association of Thailand. Opinions on the use of cannabis in neurosis for healthcare professionals. Thai Journal of Neurology. 2021; 36(2): 66-70.

Department of Thai Traditional and Alternative Medicine. Guidelines for using cannabis oil (Doctor Decha formula) produced under the special access scheme (Special Access Scheme) in health care facilities.; 2020.

Voon V, Saint-Cyr J, Lozano AM, Moro E, Poon YY, Lang AE. Psychiatric symptoms in patients with Parkinson disease presenting for deep brain stimulation surgery. Journal of neurosurgery. 2005; 103(2): 246-51.

Fernández M, Gobartt AL, Balañá M. Behavioural symptoms in patients with Alzheimer's disease and their association with cognitive impairment. BMC neurology. 2010; 10(1): 1-9.

Samanan Thasaneesuwan and Kittikorn Nilmanat. Psychological Distress in Patient with Cancer Undergoing Chemotherapy and Nursing Care. Songklanagarind Journal of Nursing, Volume 39 No. 4 October - December 2019: 110-119.

Jobsubin J and Thavichachart N. Prevalence of anxiety and depression and related factors in breast cancer patients receiving chemotherapy at King Chulalongkorn Memorial Hospital. Chula Mef J. 2009; 53(5): 428-40.

Ratree talchue and Chanokporn Jitpanya. Factors Related to Depression in Patients with Epilepsy: A Systematic Review. Princess of Naradhiwas University Journal 2012; 4(3): 1-13.

Sarısoy G, Terzi M, Gümüş K, Pazvantoğlu O. Psychiatric symptoms in patients with multiple sclerosis. General hospital psychiatry. 2013; 35(2): 134-40.

Health service system development committee (Service Plan) in the field of medical marijuana use. Guidelines for the development of health service systems (Service Plan) in the field of medical marijuana use Medical Cannabis Clinic that combines modern medicine and Thai traditional medicine in a medical facility. Under the Office of the Permanent Secretary, Ministry of Public Health. Nonthaburi: Division of Public Health Administration; 2019.

Brown JD, Costales B, van Boemmel-Wegmann S, Goodin AJ, Segal R, Winterstein AG. Characteristics of older adults who were early adopters of medical cannabis in the Florida medical marijuana use registry. Journal of clinical medicine. 2020; 9(4): 1166.

Faculty of Medicine Ramathibodi Hospital, Mahidol University. Causes of Insomnia in the Elderly, 2017. Retrieved from https://bit.ly/3GWuTy5.

Narisa Kamkaen and Charoen Treesak. Medicinal Cannabis for Cancer. The Journal of Chulabhorn Royal Academy. 2019; 1(1): 16-29.

Teerawat Hemajutha, Prasert Mongkhonsiri, Supaporn Meelarp, Chin Ratithamkul and Suthep Laohawattana. A Guide to Cannabis Use. for effective prevention and treatment of disease. Bangkok: Gokoprint (Thailand); 2020.

Subcommittee on the use of medical marijuana. Advice for doctors on the use of medical marijuana, Vol. 1, 2019.

Woodbridge M. Basics about medical marijuana. 2019.

Turna J, Balodis I, Munn C, Van Ameringen M, Busse J, MacKillop JJCp. Overlapping patterns of recreational and medical cannabis use in a large community sample of cannabis users. 2020;102:152188.